Articles published by Melinta Therapeutics, LLC
![](https://mms.businesswire.com/media/20240523275178/en/1088950/5/thumbnail_large_MLNT_new.jpg)
![](https://mms.businesswire.com/media/20231205775801/en/1088950/5/thumbnail_large_MLNT_new.jpg)
Via Business Wire
![](https://mms.businesswire.com/media/20231011988241/en/1088950/5/thumbnail_large_MLNT_new.jpg)
![](https://mms.businesswire.com/media/20230731503214/en/1852346/5/Rezzayo-vial.jpg)
![](https://mms.businesswire.com/media/20230710869070/en/1088950/5/thumbnail_large_MLNT_new.jpg)
![](https://mms.businesswire.com/media/20230515005032/en/1088950/5/thumbnail_large_MLNT_new.jpg)
![](https://mms.businesswire.com/media/20230322005767/en/1088950/5/thumbnail_large_MLNT_new.jpg)
![](https://mms.businesswire.com/media/20230125005605/en/1088950/5/thumbnail_large_MLNT_new.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Melinta Therapeutics & OptimizeRx Announce 2022 Innovate4Outcomes Event
November 30, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20221018005967/en/1605839/4/image004.jpg)
![](https://mms.businesswire.com/media/20220727005505/en/1088950/5/thumbnail_large_MLNT_new.jpg)
![](https://mms.businesswire.com/media/20220406005971/en/1088950/5/thumbnail_large_MLNT_new.jpg)
![](https://mms.businesswire.com/media/20220314005500/en/1088950/5/thumbnail_large_MLNT_new.jpg)
![](https://mms.businesswire.com/media/20220105006048/en/1320318/4/christine-ann-miller_copy.jpg)
![](https://mms.businesswire.com/media/20211025005090/en/1088950/5/thumbnail_large_MLNT_new.jpg)
![](https://mms.businesswire.com/media/20210706005112/en/1088950/5/thumbnail_large_MLNT_new.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.